Cobra Biologics Ltd.

31 articles with Cobra Biologics Ltd.

• Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant

  2/7/2018

  The grant will position the partner companies as globally recognised centres of excellence in the field and firmly establish commercial viral vector manufacturing capabilities within the UK.

• Cobra Biologics Awarded $3.4M From Innovate UK

  1/23/2018

  The extended capacity and capability will allow Cobra increased process development, analytics and GMP manufacturing.

• Cobra Biologics Wins 'Company of the Year' and ‘Technical Services’ Awards in Double Success at 2017 Bionow Awards

  12/4/2017

  Cobra Biologics is very proud to have been named as Company of the Year as well as being presented with the Technical Service Award in this year’s Bionow Awards.

• Cobra Biologics Ltd. Embarks on £15 Million Gene Therapy Manufacturing Operations Expansion, to Create Up to 50 New Jobs

  4/18/2017

• Phase I Clinical Trial Completes Using Cell Line Expertise At Cobra Biologics Ltd.

  4/3/2017

• Cobra Biologics Ltd. Wins "CMO Leadership Award" In Five Categories

  3/23/2017

• NEUWAY Pharma And Cobra Biologics Ltd. Collaborate To Develop GMP Grade Engineered Protein Capsules (EPCs) Manufacturing Process

  10/11/2016

• Cobra Biologics Ltd. And Alligator Bioscience Extend Drug Development Partnership

  6/23/2016

• Cobra Biologics Ltd. And Touchlight Collaborate On Production Of Next Generation DNA Constructs

  6/7/2016

• Cobra Biologics Ltd. Appointed By University of Sheffield To Advance Novel Fusion Protein Technology Into Phase 1 Clinical Trials

  11/23/2015

• Cobra Biologics Ltd. And University of Manchester Announce Collaboration To Improve Industrial Scale-Up Of Mammalian Cell Bioprocessing

  9/24/2015

• Cobra Biologics Ltd. Wins prestigious CMO Leadership Award For Productivity

  6/5/2015

• Cobra Biologics Ltd. Appoints CSO

  5/6/2014

• Cobra Biologics Ltd. Granted Approval For Research Tax Credit

  4/1/2014

• Cobra Biologics Ltd. And BioCancell Therapeutics Announce Agreement To Manufacture Promising Cancer Therapy Drug

  3/3/2014

• GMP Certification Boost For Cobra Biologics Ltd.

  2/11/2014

• Cobra Biologics Ltd. Expands Antibody GMP Production Capacity

  10/28/2013

• Cobra Biologics Ltd. Release: Reducing Volume Losses During Fill and Finish

  10/22/2013

• Cobra Biologics Ltd. and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection

  6/11/2013

• Cobra Biologics Ltd. and Recopharma AB Enter Agreement to Utilise Cobra's Cell Line Development Service- MaxXpress

  5/28/2013